Avidity Biosciences
RNA
#1844
Rank
HK$87.75 B
Marketcap
HK$568.10
Share price
-0.29%
Change (1 day)
118.83%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: HK$87.75 Billion

As of February 2026 Avidity Biosciences has a market cap of HK$87.75 Billion. This makes Avidity Biosciences the world's 1844th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$87.75 B3.78%
2025HK$84.56 B203.2%
2024HK$27.88 B398.36%
2023HK$5.59 B-51.43%
2022HK$11.52 B32.57%
2021HK$8.69 B17.08%
2020HK$7.42 B

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of Avidity Biosciences was reported to be:

HK$85.59 Billion
by Nasdaq info icon info icon
HK$87.75 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
HK$1.189 T 1,255.41%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$901.96 B 927.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
HK$16.15 B-81.60%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
HK$46.35 B-47.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
HK$1.03 B-98.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
HK$6.41 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
HK$85.39 B-2.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
HK$24.06 B-72.58%๐Ÿ‡บ๐Ÿ‡ธ USA